- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.3389/fphar.2021.671640
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2021
- Creator
- DOI
-
10.18154/RWTH-CONV-249169
- URN
-
urn:nbn:de:101:1-2022092301344035934901
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Acharya, Pragyan
- Chouhan, Komal
- Weiskirchen, Sabine
- Weiskirchen, Ralf
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2021
Other Objects (12)
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Cellular and Molecular Mechanisms of Insulin Resistance
Cellular and Molecular Mechanisms of Insulin Resistance
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Editorial : Inflammation and Fibrosis in the Gastrointestinal Tract and LiverMechanisms and Targets
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Cellular and Molecular Mechanisms of Insulin Resistance
Cellular and Molecular Mechanisms of Insulin Resistance
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Editorial : Inflammation and Fibrosis in the Gastrointestinal Tract and LiverMechanisms and Targets
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Cellular and Molecular Mechanisms of Insulin Resistance
Cellular and Molecular Mechanisms of Insulin Resistance
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Editorial : Inflammation and Fibrosis in the Gastrointestinal Tract and LiverMechanisms and Targets